Simulations Plus(SLP) - 2024 Q1 - Earnings Call Presentation

2 CURRENT PERIOD | --- | --- | --- | --- | |------------------------------|-------------|-------------|---------| | | | | | | Prior Year Comparison (1Q23) | | | | | $12.0M | $0.06 | 25% | $15.8M | | Revenue | Diluted EPS | Adjusted | Backlog | | | | EBITDA as % | | | | | of Revenue | | GastroPlus® (Physiologically Based Pharmacokinetics) Q1 Revenue Growth General | --- | --- | |--------------------|-------------------------------------------------------------------------------------------------------------- ...